Necroptosis: The Regulation Between EGFR and TNFR in Cancer

Area of Science:

• Oncology
• Molecular Biology
• Cell Death Mechanisms

Background:

• Cancer remains a leading cause of death due to complex mechanisms like tumorigenesis and therapeutic resistance.
• Conventional therapies (chemotherapy, targeted therapy, immunotherapy) face challenges from cancer cell plasticity and multidrug resistance.
• Cancer cells employ sophisticated evasion strategies to bypass programmed cell death and maintain proliferation, survival, and metastasis.

Purpose of the Study:

• To review the role of necroptosis-based therapies in suppressing tumorigenesis and enhancing treatment outcomes.
• To elucidate the mechanisms by which targeting the epidermal growth factor receptor (EGFR)-tumor necrosis factor receptor (TNFR) signaling pathway inhibits tumorigenesis via necroptosis.
• To propose this pathway as an innovative targeted therapy for treatment-resistant cancers.

Main Methods:

• Review of existing literature on cancer therapy, resistance mechanisms, and necroptosis.
• Analysis of signaling pathways involving EGFR and TNFR in the context of cancer cell death.
• Delineation of the molecular mechanisms underlying EGFR- and TNFR-mediated necroptosis induction.

Main Results:

• Necroptosis-based therapies show promise in inhibiting tumorigenesis and improving outcomes across various cancer types.
• Targeting overexpressed receptors on cancer cells is a key strategy for suppressing tumorigenesis.
• Regulation of the EGFR-TNFR signaling pathway through necroptosis offers a mechanism to inhibit cancer growth.

Conclusions:

• Inducing necroptosis via the EGFR-TNFR pathway represents a novel therapeutic paradigm.
• This approach holds potential for enhancing clinical outcomes in patients with treatment-resistant cancers.
• Targeting necroptosis offers a strategy to overcome cancer plasticity and multidrug resistance.